Lineage Cell Therapeutics
LCTX
#8742
Rank
$0.11 B
Marketcap
$0.54
Share price
-1.91%
Change (1 day)
-51.96%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $31.8 Million USD

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are $31.8 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$38.99 M-24.61%
2022-12-31$51.72 M-38.16%
2021-12-31$83.64 M552.37%
2020-12-31$12.82 M-9.9%
2019-12-31$14.23 M51.17%
2018-12-31$9.41 M4.86%
2017-12-31$8.97 M-25.58%
2016-12-31$12.06 M-33.76%
2015-12-31$18.21 M49.56%
2014-12-31$12.17 M-21.27%
2013-12-31$15.46 M183.59%
2012-12-31$5.45 M24.77%
2011-12-31$4.37 M13.63%
2010-12-31$3.84 M61.23%
2009-12-31$2.38 M-55.67%
2008-12-31$5.38 M67.07%
2007-12-31$3.22 M28.05%
2006-12-31$2.51 M16.72%
2005-12-31$2.15 M83.15%
2004-12-31$1.17 M-66.4%
2003-12-31$3.5 M31.3%
2002-12-31$2.66 M30.72%
2001-12-31$2.04 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$28.07 M-11.71%๐Ÿ‡บ๐Ÿ‡ธ USA